Stefan Sowa has been appointed as CEO of Endovascular Development AB (Endovab®). He most recently served as CEO of Novus Scientific AB.
Sowa has held leading positions in the life science sector for more than 25 years. During his six years at Novus the company became a manufacturing establishment approved according to ISO13485 and GMP with sales in 27 countries of surgical implant products. Before his time at Novus he was production manager for 10 years for cardiovascular products at Radi Medical Systems AB / St Jude.
His many roles have given Sowa broad experience of growing knowledge-intensive companies in the health care sector.
“Endovab’s proprietary arterial anchoring technology has a great potential in the growing market of endovascular tools and the established clinical experience and network is a fantastic foundation to build a successful company”, says Sowa.